This article is more than 5 years old. Information may no longer be current.

VIDEO: New drug delivery systems replacing outdated eye drops

ByCynthia Matossian, MD, FACS

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WAIKOLOA, Hawaii — At Hawaiian Eye 2019, Cynthia A. Matossian, MD, FACS, discusses her presentation on long-term methods of delivering medication to the eye after cataract surgery, thus bypassing the “prehistoric” eye drop delivery method. Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) is an intracanalicular insert. Dexycu (dexamethasone intraocular suspension, EyePoint Pharamaceuticals) 9% is administered through a single intraocular dose behind the iris. Both deliver medication for up to 30 days.